Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mirvaso
Brimonidine tartrate 5mg/g equivalent to brimonidine 3.3mg/g
Topical gel
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Laboratoires Galderma, Alby-sur-Cheran, France
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
VPRIV
Velaglucerase alfa 400U
Powder for infusion concentrate
Shire New Zealand Limited
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Cangene bioPharma, Maryland, United States of America
|
Dated this 6th day of May 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz